Cough and cold medicines should not be given to children under sixChildren under six years of age should not be given over-the-counter (OTC) cough and cold medication, a new Health Canada advisory said. CPSO passes new first-come first-served patient policy in Ont.OMA says policy represents a human rights ‘double jeopardy’ Ethics poll of Canadian MDs finds strongly held views Big responses seen for right to not offer procedures due to religious beliefs and condemning deception ‘in patient’s best interest’ Hand in hand, on the path to change Holiday Hell in the ER 'A skeleton staff in every department' Infanrix hexa: new combined vaccine for infants GlaxoSmithKline is introducing Infanrix hexa. Manitoba’s FP-specialist referral project holds promise Specialist catalogue being developed will include wait-time data Med Post advisory member was a true Renaissance man New type of self-harming disorder observed in teens Abused girls embed objects in their skin to deal with trauma Now boarding, additional MDs? B.C. government and BCPhA announce drug-pricing agreement B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy. New pediatric indication for Reyataz Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age. First Previous 2012 2013 2014 2015 2016 Next Last
